Cargando…
Thrombocytosis as a Biomarker in Type II, Non-Endometrioid Endometrial Cancer
Thrombocytosis (platelets ≥ 400K) is a common hematologic finding in gynecologic malignancies and associated with worse outcomes. Limited data exist on the prognostic capability of thrombocytosis in women with high-grade endometrial cancer (EC). Our objective was to describe the associations between...
Autores principales: | Bussies, Parker, Eta, Ayi, Pinto, Andre, George, Sophia, Schlumbrecht, Matthew |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7563482/ https://www.ncbi.nlm.nih.gov/pubmed/32842701 http://dx.doi.org/10.3390/cancers12092379 |
Ejemplares similares
-
Endometrial cancer among a cohort of urban Haitian immigrants
por: Schlumbrecht, Matthew, et al.
Publicado: (2019) -
Preoperative thrombocytosis as a prognostic factor in endometrioid-type endometrial carcinoma
por: Abu-Zaid, Ahmed, et al.
Publicado: (2017) -
Role of serum microRNAs as biomarkers for endometriosis, endometrioid carcinoma of ovary & endometrioid endometrial cancer
por: Kumari, Priti, et al.
Publicado: (2022) -
Unique Considerations in Early Detection, Risk, and Awareness of Endometrial Cancer in Black Women
por: Schlumbrecht, Matthew, et al.
Publicado: (2023) -
Biomarkers Associated with Lymph Nodal Metastasis in Endometrioid Endometrial Carcinoma
por: Mairé, Mathilde, et al.
Publicado: (2022)